The feared-failure taxonomy and recognition cues are established in The Evaluator's Lens and the accountability tests. This piece covers the response. Six feared failures — model-behavior unreliability, adoption collapse, platform incoherence, organizational capability gap, consequential harm, and execution-speed failure — each with specific choreography: which evidence leads, which supports, which sits out, how TinyFish shifts roles, which forward-looking domain surfaces, and a rehearsed moment that tests your judgment when a constraint changes. Search committees reconvened after Labor Day with compressed timelines. Everything here is organized by what the evaluator is afraid of, not by what's in your portfolio.
The changed constraint
The evaluator already knows your case study resolves. What they need to see is whether your judgment holds when the resolution breaks.
The technique: at one natural moment in your walkthrough, change a key constraint. Budget halved. Timeline compressed. A stakeholder reverses a priority. A model release degrades performance. Say it plainly — "Here's what changes if this constraint shifts" — and walk through the revised response in thirty to sixty seconds.
Rehearse one per feared failure. The constraint you change must map to the fear. If the evaluator is worried about speed, compress the timeline. If they're worried about harm, degrade the safety gate. A mismatched constraint change wastes the moment.
TinyFish has four permitted roles, and they shift by feared failure: recent role context, technical AI currency, grounding for forward-looking artifacts, and bridge narrative. Never portfolio proof.
1. Model-behavior unreliability
The fear: You talk a strong AI strategy but have no answer when the model gets slow, wrong, confidently wrong, or altered by a provider release.
Lead with the Trust essay and whichever Lab app best shows evidence states and behavioral variance in a live application. Brand Pulse if the conversation centers on monitoring and inference quality. Carrier IQ if it centers on review authority before commitment. In a live review where you can walk through original work, an Inference-Aware UX artifact — clearly labeled as in-progress — can lead instead. Do not send it async until the URL is stable and cleared.
Support with Thermo Fisher (BCG Digital Ventures). The exception-first architecture and preserved human QA release gate show you design for the moment the system is wrong.
Sits out: Equinox+, Alle. Strong outcome cases, but neither contains a design decision shaped by model confidence, latency, or behavioral variance. They dilute before you've established the model-behavior signal.
TinyFish role: Technical AI currency and grounding for the forward artifact. Past tense. You worked inside an agentic production system. That proximity informs how you think about degraded states. Do not show TinyFish screens or cite its metrics.
Forward domain: Inference-Aware UX — interaction behavior that changes when model confidence, latency, or reliability changes. The artifact should show degraded states, evidence thresholds, failure signals, and a condition that invalidates the current design.
Changed constraint: You're walking through the Thermo Fisher future-state architecture where agents flag at-risk batches. A model release reduces latency but increases confident false negatives on batch risk. Walk through what changes: the threshold for human review, the evidence density at the review gate, the release rule, the recovery path when a bad batch clears, and the criterion you'd set before accepting the next model version. The evaluator needs to see that you've already thought about what happens when the model improves in one dimension and degrades in another.
2. Adoption collapse
The fear: You build products that look right but nobody uses, or that activate users but can't hold them.
Lead with Alle (BCG Digital Ventures). The outcome chain is specific and traceable: 3.2x redemption increase, 47% lapsed-member reactivation, $42 CAC, expiry notification cited by 68% of reactivating members. That's a path from design decision to activation to retention to reactivation mechanism.
Support with Alibaba — 7% DAU increase, 20% daily transaction increase, 47% new visitor increase from search. Use the Labs apps only to maintain AI currency, not as adoption evidence. The Labs have no published user-adoption or retention metrics.
Sits out: Thermo Fisher and Red Cross as openers. Their outcome stories are about operational efficiency and mission delivery, not user acquisition or retention curves. An evaluator afraid of adoption collapse will hear "partner adoption" or "cases opened" and wonder where the growth engine is. If the adoption problem is also regulated or multi-party, they can support — but they don't lead.
TinyFish role: Recent role context or bridge narrative. You moved into product leadership to understand AI-native systems from the inside. Do not cite TinyFish growth numbers or internal product metrics.
Forward domain: Intent-Based Interaction — relevant when the AI product's adoption failure starts with users not understanding what the system can do or what it needs from them. The artifact should show how structured intent-setting and explicit capability boundaries close the gap between what the user expects and what the system delivers. That's the activation-layer problem that precedes any retention fix. The business-outcome proof still comes from Alle and Alibaba.
Changed constraint: You're walking through Alle. Provider participation drops, or the success measure shifts from redemption volume to sustained 90-day retention. Walk through which surface changes, which signal you'd instrument first, which experiment you'd run, and what you'd cut from the current experience to make room. This evaluator needs to see you think about adoption as a system with multiple failure points, not a single funnel you optimize from the top.
3. Platform incoherence
The fear: You make strong decisions inside one product but can't hold coherence across surfaces, teams, or release cycles.
Lead with Alibaba. Three cross-functional sprints across homepage, search, and product detail — each surface serving a different moment in B2B procurement, sharing trust signals (Trade Assurance, verified status, supplier tenure, inspection evidence) that had to behave consistently across all three. The outcomes are platform-level: $50B+ GMV context, 20% transaction increase, 2.2-point NPS increase.
Support with Thermo Fisher (BCG Digital Ventures) for coherence across organizational boundaries — one operating system serving six pharma partners across nine sites, with shared KPIs visible to both Thermo Fisher and partner teams. Use Alle or Equinox+ when dual-surface or multi-brand coherence is closer to the target company's actual problem. If the target company operates in IoT, fleet, or connected field operations, add Cummins/ZED Connect (BCG Digital Ventures) — multi-stakeholder coherence across field and office surfaces is its specific domain.
Sits out: Agentic Labs apps as openers, unless the platform explicitly includes agent-facing surfaces. The Labs demonstrate product judgment within a single application boundary; they don't show cross-surface governance and propagation decisions. Red Cross stays secondary unless system consolidation (six legacy systems into one) is the evaluator's exact concern.
TinyFish role: Bridge narrative or recent context only.
Forward domain: Agent Infrastructure as UX — relevant when coherence must extend across human interfaces, agent permissions, API surfaces, and review layers.
Changed constraint: You're walking through Alibaba. One product team — say, Search — rejects the shared supplier-trust pattern because displaying verification badges in search results depresses its click-through rate. Walk through the governance response: where the exception gets evaluated, what evidence the team needs to bring, what the portfolio-level consequence is if the pattern fragments, and how you'd resolve it without overriding the team or abandoning the shared standard. This evaluator needs to see a decision mechanism, not a mandate.
4. Organizational capability gap
The fear: You can do the work yourself but can't build, grow, or elevate a team that does it without you.
Lead with Alibaba. You created the mandate — named the gap, built the research case, secured executive buy-in — and led a cross-functional team spanning design, research, product, and engineering. You grew the design team from six to more than twelve. The story is that you built the organizational conditions for the redesign to happen and the team to sustain it after you left.
Support with Equinox+ (BCG Digital Ventures) for coordinating a small design and research team across five brands with a shared component architecture. Use the Trust essay and Labs only when the capability gap is specifically about building AI practice — upskilling, new workflows, new review mechanisms.
Sits out: Solo Labs apps as proof of team leadership. They show product judgment. They do not show hiring, coaching, critique cadence, or quality calibration across a team.
TinyFish role: Bridge narrative and recent-role context. You led product at a company building agentic systems. Do not claim that confidential TinyFish work proves function-building.
Forward domain: Human-Agent System Design — relevant when the capability problem involves defining roles, decision rights, review responsibilities, and repeatable human-AI operating standards across a team.
Changed constraint: You're walking through Alibaba. The approved hiring plan disappears — budget frozen — or the team doubles overnight through an acquisition without a new management layer. Walk through which commitments stop, which quality mechanism changes, which decisions you hold personally versus distribute, and how you communicate the revised scope to stakeholders who expected the original plan. The evaluator is looking for organizational thinking that holds when the organizational plan falls apart.
5. Consequential harm
The fear: You design clean workflows but haven't identified the point where a mistake becomes irreversible.
Lead with Thermo Fisher (BCG Digital Ventures). The exception-first architecture — making at-risk batches the default view instead of burying them in a flat list of 197 orders — and the preserved human batch-release gate. Exceptions caught a week before the delivery gate cost three to five times less to resolve than exceptions caught at the gate. The $20M margin opportunity and 100% partner adoption are the outcome layer.
Support with Red Cross (BCG Digital Ventures) — verification gates, disbursement controls, fraud holds, duplicate detection, supervisor-only approvals, and audit evidence captured without adding fields to the volunteer's intake. Add Carrier IQ for inspectable AI review and approval authority — the "Approve Bind" gate, side-by-side carrier results, evidence attachment, and re-verification states. When the domain involves fleet or field operations where a wrong decision has physical-world consequences, add Cummins/ZED Connect (BCG Digital Ventures).
Sits out: Equinox+ and Alibaba as lead cases. They demonstrate scale and coherence, but neither surfaces the irreversibility question that defines this fear. Alle is a consumer engagement product, not regulated-compliance proof.
TinyFish role: Technical AI currency and grounding for the forward artifact. You understand agent auditability, attribution, and reversibility from production proximity. TinyFish is not evidence of safe design.
Forward domain: Human-Agent System Design — actor roles, decision rights, evidence obligations, escalation, containment, recovery, and what changes in the next run.
Changed constraint: You're walking through Thermo Fisher. The QA reviewer now has twenty seconds instead of the normal review window, or lacks the relevant domain expertise, or cannot reverse a batch release once approved. Walk through whether the original human gate still functions under those conditions — and if it doesn't, what must change in evidence density, escalation triggers, stop authority, and the recovery path. This evaluator needs to see that you've thought about the conditions under which the human gate itself fails.
6. Execution-speed failure
The fear: You're a process-heavy enterprise designer who can't ship under real constraints.
Lead with Equinox+ (BCG Digital Ventures). Zero to MVP in three months. A late decision to launch SoulCycle, Equinox, and Pure Yoga while moving Precision Run and HeadStrong post-MVP. The scope cut is the story — what to cut, what quality bar didn't move, and what you could no longer promise.
Support with Red Cross (BCG Digital Ventures) for speed under consequence — six months to national deployment during an active disaster-response cycle, with $847,000 disbursed and 1,689 cases opened in the first two weeks. Or Thermo Fisher for a 12-month cross-partner 0-to-1 build when the concern is delivery complexity rather than raw pace.
Sits out: Alibaba as the opener. The enterprise scale signal can reinforce a "too slow, too process-heavy" read before you've resolved the speed question. Bring Alibaba in after you've established shipping evidence.
TinyFish role: Recent-role context only. You were Head of Product at a startup. That's speed context. Do not cite confidential throughput claims.
Forward domain: Intent-Based Interaction as a compact build or prototype demonstration — but not as the primary speed proof. The speed proof comes from shipped products with timelines.
Changed constraint: You're walking through Equinox+. Compress the timeline from three months to six weeks, or halve engineering capacity. Walk through what gets removed, which brand stays in the MVP, what quality bar does not move and why, and which outcome you can no longer promise the stakeholder. This evaluator needs to see that you know what to sacrifice and what to protect, and that you make that call explicitly rather than letting the timeline make it for you.
Before you walk in
Answer one question: what is this evaluator afraid of hiring?
The recognition cues are in the interview structure, the posting language, and the questions they lead with.
- Model-behavior fears surface as evals, latency, degraded states.
- Adoption fears surface as activation, retention, funnel ownership.
- Coherence fears surface as platform, shared patterns, cross-product consistency.
- Capability fears surface as hiring plan, team quality, critique cadence.
- Consequence fears surface as failure states, reversal, escalation, audit.
- Speed fears surface as shipping pace, personal contribution, timeline, scope cuts.
Once you've identified the fear, the choreography above tells you what to reach for. The case that leads for one fear sits out for another. TinyFish, the forward domain, and the changed constraint all shift accordingly.
When two fears overlap — consequential harm and execution speed, model unreliability and platform incoherence — lead with the one that carries screening risk, the fear that could eliminate you before conversation starts. Support with the second. If both surface live, lead with whichever the evaluator raised first and bridge to the second through your changed-constraint moment.
- Forward-looking artifacts remain unbuilt: The September 12 site check found no independently linkable public page for Inference-Aware UX, Intent-Based Interaction, Agent Infrastructure as UX, or Human-Agent System Design — which means every async outreach still routes through the Trust essay and Labs rather than the domain that would actually lead for AI-native feared failures.
- Living evidence over finished artifacts: NIST's 2026 deployment-monitoring report argues that controlled pre-release evaluations are insufficient for nondeterministic AI systems, which supports building forward-looking portfolio work as versioned evidence cases rather than polished speculative screen sets.
- TinyFish's homepage prominence still conflicts: The current site places TinyFish first under "Selected work" and links a new Coca-Cola × TinyFish case-like page, while the standing evidence policy classifies TinyFish as context only — a gap that could undercut the careful role-shifting this piece depends on.
- Realistic previews reduce churn: A meta-analysis of 40 studies found that realistic job previews — communicating both positive and negative aspects of a role — were associated with lower turnover and more accurate expectations, which gives empirical weight to treating the interview as two-way evidence rather than a one-sided audition.